Cancer genome: highlights of a Nature Medicine perspective

Por Voest, Emile
Publicado no ESMO Open (2016)

Intravital characterization of tumor cell migration in pancreatic cancer

Por Beerling, Evelyne, Oosterom, Ilse, Voest, Emile, Lolkema, Martijn, van Rheenen, Jacco
Publicado no Intravital (2016)

Dexrazoxane pre-treatment protects skinned rat cardiac trabeculae against delayed doxorubicin-induced impairment of crossbridge kinetics

Por Beer, Evert L de, Bottone, Antonio E, Rijk, Maartje C van, Velden, Jolanda van der, Voest, Emile E
Publicado em 2002

Phase 1/2 Study of Atrasentan Combined with Pegylated Liposomal Doxorubicin in Platinum-Resistant Recurrent Ovarian Cancer

Por Witteveen, Petronella O, van der Mijn, Koen JC, Los, Maartje, Kronemeijer, Roelien H, Groenewegen, Gerard, Voest, Emile E
Publicado em 2010

Are health care professionals able to judge cancer patients' health care preferences correctly? A cross-sectional study

Por Kruitwagen Cas LJJ, de Heus Miriam, Wynia Klaske, de Graeff Alexander, Wessels Hester, Teunissen Saskia CCM, Voest Emile E
Publicado em 2010-07-01

LRRC50, a Conserved Ciliary Protein Implicated in Polycystic Kidney Disease

Por van Rooijen, Ellen, Giles, Rachel H., Voest, Emile E., van Rooijen, Carina, Schulte-Merker, Stefan, van Eeden, Freek J.
Publicado em 2008

Low-Dose Metronomic Cyclophosphamide Combined with Vascular Disrupting Therapy Induces Potent Anti-Tumor Activity in Preclinical Human Tumor Xenograft Models

Por Daenen, Laura G., Shaked, Yuval, Man, Shan, Xu, Ping, Voest, Emile E., Hoffman, Robert M., Chaplin, David, Kerbel, Robert S.
Publicado em 2009

Are health care professionals able to judge cancer patients' health care preferences correctly? A cross-sectional study

Por Wessels, Hester, de Graeff, Alexander, Wynia, Klaske, de Heus, Miriam, Kruitwagen, Cas LJJ, Teunissen, Saskia CCM, Voest, Emile E
Publicado em 2010

Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review

Por Walraven, Maudy, Witteveen, Petronella O., Lolkema, Martijn P. J., van Hillegersberg, R., Voest, Emile E., Verheul, H. M. W.
Publicado em 2010

Distinct phosphatases antagonize the p53 response in different phases of the cell cycle

Por Shaltiel, Indra A., Aprelia, Melinda, Saurin, Adrian T., Chowdhury, Dipanjan, Kops, Geert J. P. L., Voest, Emile E., Medema, René H.
Publicado em 2014

Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue

Por Basten, Sander G, Willekers, Sven, Vermaat, Joost SP, Slaats, Gisela GG, Voest, Emile E, van Diest, Paul J, Giles, Rachel H
Publicado em 2013

Late Release of Circulating Endothelial Cells and Endothelial Progenitor Cells after Chemotherapy Predicts Response and Survival in Cancer Patients

Por Roodhart, Jeanine M, Langenberg, Marlies H, Vermaat, Joost S, Lolkema, Martijn P, Baars, Arnold, Giles, Rachel H, Witteveen, Els O, Voest, Emile E
Publicado em 2010

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

Por Holleman, Amy, Chung, Ivy, Olsen, Rachelle R., Kwak, Brian, Mizokami, Atsushi, Saijo, Nagahiro, Parissenti, Amadeo, Duan, Zhenfeng, Voest, Emile E., Zetter, Bruce R.
Publicado em 2011

Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered

Por Bijlsma, Rhodé M, Bredenoord, Annelien L, Gadellaa-Hooijdonk, Christa G, Lolkema, Martijn PJ, Sleijfer, Stefan, Voest, Emile E, Ausems, Margreet GEM, Steeghs, Neeltje
Publicado no Eur J Hum Genet (2016)

Phase 1 Study of Combination Treatment with PTK 787/ZK 222584 and Cetuximab for Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics Analysis

Por Langenberg, Marlies HG, Witteveen, Petronella O, Lankheet, Nienke AG, Roodhart, Jeanine ML, Rosing, Hilde, van den Heuvel, Ingeborg JGM, Beijnen, Jos H, Voest, Emile E
Publicado em 2010

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum

Por Greijer, Astrid E., Delis-van Diemen, Pien M., Fijneman, Remond J. A., Giles, Rachel H., Voest, Emile E., van Hinsbergh, Victor W. M., Meijer, Gerrit A.
Publicado em 2008

Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint

Por Kleiblova, Petra, Shaltiel, Indra A., Benada, Jan, Ševčík, Jan, Pecháčková, Soňa, Pohlreich, Petr, Voest, Emile E., Dundr, Pavel, Bartek, Jiri, Kleibl, Zdenek, Medema, René H., Macurek, Libor
Publicado em 2013

Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance

Por Ariës, Ingrid M., van den Dungen, Rosanna E., Koudijs, Marco J., Cuppen, Edwin, Voest, Emile, Molenaar, Jan J., Caron, Huib N., Pieters, Rob, den Boer, Monique L.
Publicado no Haematologica (2015)

Liver Regeneration Is an Angiogenesis- Associated Phenomenon

Por Drixler, Tom A., Vogten, Mathys J., Ritchie, Ewan D., van Vroonhoven, Theo J. M. V., Gebbink, Martijn F. B. G., Voest, Emile E., Borel Rinkes, Inne H. M.
Publicado em 2002

Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases

Por Brandsma, Dieta, Ulfman, Laurien, Reijneveld, Jaap C., Bracke, Madelon, Taphoorn, Martin J.B., Zwaginga, Jaap Jan, Gebbink, Martijn F.B., de Boer, Hetty, Koenderman, Leo, Voest, Emile E.
Publicado em 2006